Neuropace NPCE
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 15.44 | 156.51 | -0.08 | -1,767 | -3 | |
| 2025Q3 | 10.31 | 140.46 | -0.11 | -2,600 | -3 | |
| 2025Q2 | 11.14 | 103.52 | -0.26 | -6,824 | -9 | |
| 2025Q1 | 12.29 | 116.03 | -0.21 | -5,147 | -7 | |
| 2024Q4 | 11.19 | 119.46 | -0.17 | -3,653 | -5 | |
| 2024Q3 | 6.97 | 129.76 | -0.18 | -4,243 | -5 | |
| 2024Q2 | 7.56 | 116.49 | -0.26 | -6,230 | -8 | |
| 2024Q1 | 13.20 | 113.17 | -0.32 | -7,545 | -9 | |
| 2023Q4 | 10.31 | 127.42 | -0.22 | -5,051 | -6 | |
| 2023Q3 | 9.73 | 117.45 | -0.28 | -5,950 | -7 | |
| 2023Q2 | 4.49 | 112.22 | -0.36 | -7,854 | -9 | |
| 2023Q1 | 4.64 | 98.92 | -0.41 | -8,319 | -10 | |
| 2022Q4 | 1.49 | 107.10 | -0.44 | -9,859 | -11 | |
| 2022Q3 | 3.75 | 103.24 | -0.48 | -10,199 | -12 | |
| 2022Q2 | 4.95 | 101.25 | -0.52 | -10,974 | -13 | |
| 2022Q1 | 8.21 | 101.36 | -0.47 | -9,762 | -11 | |
| 2021Q4 | 10.08 | 102.08 | -0.36 | -9,015 | -11 | |
| 2021Q3 | 15.85 | 99.78 | 0.12 | -6,243 | -8 | |
| 2021Q2 | 23.79 | 69.55 | 30.80 | -4,605 | -8 | |
| 2021Q1 | 55.65 | -32.73 | -3,874 | -9 |